Successful treatment of Chromobacterium violaceum sepsis in South Africa

Bosch, F. J.; Badenhorst, L.; Roux, J. A. Le; Louw, Vernon

doi:10.1099/jmm.0.2008/001883-0

Cited by 12 publications

(11 citation statements)

References 10 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, healthcare-associated infection was considered in two cases in this review. 32,34 One study for neonatal sepsis conducted by Anah and others in 2008 had demonstrated isolation of C. violaceum from 10 inborn neonates (6.3%). 14 These data indicate that this microorganism might have existed in hospital settings, and this warrants attention.…”

Section: Relapsementioning

confidence: 98%

“…He succumbed to uncontrolled sepsis 3 months after cervical laminoplasty. Another patient, a 16-year-old female, had received chemotherapy for acute leukemia, 34 then developed pneumonia with septic shock during hospitalization. Cultures from her blood and Hickman catheter yielded nonpigmented C. violaceum.…”

Section: Potential Predisposing Factors Associated With C Violaceum mentioning

confidence: 99%

See 1 more Smart Citation

Chromobacterium violaceum infection: A clinical review of an important but neglected infection

Yang

2011

Journal of the Chinese Medical Association

143

219

View full text Add to dashboard Cite

show abstract

Section: Relapsementioning

confidence: 98%

Section: Potential Predisposing Factors Associated With C Violaceum mentioning

confidence: 99%

Chromobacterium violaceum infection: A clinical review of an important but neglected infection

Yang

2011

Journal of the Chinese Medical Association

143

219

View full text Add to dashboard Cite

show abstract

“…Previous case series 3,18 have shown a male predominance for this organism, but infections in immunocompromised and healthy females have also been reported. 14,19 Children, often with underlying immunodeficiencies such as chronic granulomatous disease, 3,20 are known to be at risk of developing disease.…”

Section: Discussionmentioning

confidence: 99%

“…Aeromonas spp. identified to species level were A. caviae (2), A. hydrophilia (103), A. salmonicida (3), and A. sobria (14). Shewanella spp.…”

Section: Methodsmentioning

confidence: 99%

Relative Frequency, Characteristics, and Antimicrobial Susceptibility Patterns of Vibrio spp., Aeromonas spp., Chromobacterium violaceum, and Shewanella spp. in the Northern Territory of Australia, 2000–2013

McAuliffe¹,

Hennessy²,

Baird³

2015

The American Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Abstract. Vibrio, Aeromonas, Chromobacterium violaceum, and Shewanella (VACS) are water-associated Gramnegative organisms that can cause a variety of infections. The frequency, patient characteristics, and antimicrobial susceptibilities for 468 isolates from 442 patients from the Northern Territory were reviewed. Aeromonas spp. (312 of 468; 67%) were most commonly isolated followed by Vibrio spp. (71 of 468; 15%), Shewanella spp. (61 of 468; 13%), and C. violaceum (24 of 468; 5%). A strong male predominance was found (male to female ratio of 2.3:1). Skin and soft tissue isolations (373 of 468; 80%) from lower limb infections (222 of 371; 60%) were the most common clinical manifestation. The episodes were usually polymicrobial (281 of 468; 60%). Coisolates included Staphylococcus aureus (137 of 468; 29%), β-hemolytic streptococci (74 of 468; 16%), enterobacteriaceae (111 of 468; 24%), non-fermentative Gram-negative bacilli (35 of 468; 7%), and other VACS organisms (37 of 468; 8%). Antimicrobial resistance of VACS organisms to ciprofloxacin (0-4%), cefepime (0-3%), and gentamicin (0-0.8%) and Vibrio spp., Aeromonas spp., and Shewanella to cotrimoxazole (0-3%) was rarely shown. For water-associated lower limb skin and soft tissue infections in the tropics, clinicians should consider empirical antimicrobial therapy with agents active against S. aureus and VACS organisms.

show abstract

“…The infection was due to a nonpigmented strain of C. violaceum and was associated with a co-infection with Candida parapsilosis; both were successfully treated using broad-spectrum antibiotics, antifungals and removal of a Hickman line (Bosch et al 2008). …”

Section: Pathological Effects Of C Violaceummentioning

confidence: 98%

Chromobacterium violaceum and its important metabolites — review

2010

View full text Add to dashboard Cite

C. violaceum appeared as important bacterium in different applications and mainly these aspects are related to the production of violacein. This review discusses the last reports on biosynthetic pathways, production, genetic aspects, biological activities, pathological effects, antipathogenic screening through quorum sensing, environmental effects and the products of C. violaceum with industrial interest. An important discussion is on biological applications in medicine and as industrial products such as textile and in cosmetics.

show abstract

Successful treatment of Chromobacterium violaceum sepsis in South Africa

Cited by 12 publications

References 10 publications

Chromobacterium violaceum infection: A clinical review of an important but neglected infection

Chromobacterium violaceum infection: A clinical review of an important but neglected infection

Relative Frequency, Characteristics, and Antimicrobial Susceptibility Patterns of Vibrio spp., Aeromonas spp., Chromobacterium violaceum, and Shewanella spp. in the Northern Territory of Australia, 2000–2013

Chromobacterium violaceum and its important metabolites — review

Contact Info

Product

Resources

About